Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen.

Published byDella Marshall Modified over 5 years ago

Similar presentations

Presentation on theme: "Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen."— Presentation transcript:

1 Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen S. Anderson, Valluvan Jeevanadham, Jonathan D. Rich, and Atman P. Shah Circ Heart Fail Volume 6(3):e27-e29 May 21, 2013 Copyright © American Heart Association, Inc. All rights reserved.

2 Chest x-ray showing the pigtail catheter and the left ventricular assist device inflow cannula in the left ventricular cavity. Chest x-ray showing the pigtail catheter and the left ventricular assist device inflow cannula in the left ventricular cavity. Thenappan Thenappan et al. Circ Heart Fail. 2013;6:e27-e29 Copyright © American Heart Association, Inc. All rights reserved.

3 Comparison of serum lactate dehydrogenase (LDH), bilirubin, and creatinine pre- and postfibrinolytic therapy. Comparison of serum lactate dehydrogenase (LDH), bilirubin, and creatinine pre- and postfibrinolytic therapy. AC indicates anticoagulation therapy (intravenous heparin); AP, antiplatelet therapy (intravenous eptifibatide), and TPA, tissue-type plasminogen activator (alteplase). Blue represents case 1 and red represents case 2. Thenappan Thenappan et al. Circ Heart Fail. 2013;6:e27-e29 Copyright © American Heart Association, Inc. All rights reserved.

Download ppt "Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen."

Similar presentations

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Development of a Novel Echocardiography Ramp Test.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Development of a Novel Echocardiography Ramp Test.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2):223-229 July 10, 2012 Copyright.

Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):2154-2161.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):
Jennifer A. Cowger, MD, Matthew A

Jennifer A. Cowger, MD, Matthew A
Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 

Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 
Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes
Forecasting the Impact of Heart Failure in the United States

Forecasting the Impact of Heart Failure in the United States
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
by Andreia Biolo, Sujata Ramamurthy, Lawreen H. Connors, Carl J

by Andreia Biolo, Sujata Ramamurthy, Lawreen H. Connors, Carl J
Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.

Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.
Attenuation of the “White-Coat Effect” by Antihypertensive Treatment and Regression of Target Organ Damage by Gianfranco Parati, Luisa Ulian, Lorena Sampieri,

Attenuation of the “White-Coat Effect” by Antihypertensive Treatment and Regression of Target Organ Damage by Gianfranco Parati, Luisa Ulian, Lorena Sampieri,
Regulation of Circulating Progenitor Cells in Left Ventricular DysfunctionClinical Perspective by Barry A. Boilson, Katarina Larsen, Adriana Harbuzariu,

Regulation of Circulating Progenitor Cells in Left Ventricular DysfunctionClinical Perspective by Barry A. Boilson, Katarina Larsen, Adriana Harbuzariu,
Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.

Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.
Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.

Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.
CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.
CYB561 homology modeling. CYB561 homology modeling.A, Close-up of mutation G88R in CYB561. The protein is shown in ribbon presentation in gray, the heme.

CYB561 homology modeling. CYB561 homology modeling.A, Close-up of mutation G88R in CYB561. The protein is shown in ribbon presentation in gray, the heme.

Similar presentations

Ads by Google